Molecular imaging in radiotherapy planning for head and neck tumors

Vincent Grégoire, Arturo Chiti

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Molecular imaging uses noninvasive techniques to visualize various biologic pathways and physiologic characteristics of tumors and normal tissues. In relation to radiation therapy, PET with the tracer 18F-FDG offers a unique opportunity to refine the target volume delineation in patients with squamous cell carcinoma of the head and neck, in turn affecting dose distribution and, it is hoped, patient outcome. Even more so, in the framework of adaptive treatment and theragnostics, whereby dose distribution is adapted in space and time over the typical course of radiotherapy, molecular imaging with PET offers an elegant research avenue to further improve the therapeutic ratio. Such implementation could be of particular interest with tracers other than 18F-FDG, such as tracers of hypoxia and proliferation.

Original languageEnglish
Pages (from-to)331-334
Number of pages4
JournalJournal of Nuclear Medicine
Volume52
Issue number3
DOIs
Publication statusPublished - Mar 1 2011

Fingerprint

Molecular Imaging
Fluorodeoxyglucose F18
Neck
Radiotherapy
Head
Neoplasms
Therapeutics
Research
Carcinoma, squamous cell of head and neck
Hypoxia

Keywords

  • Dose painting
  • FDG
  • PET
  • Radiotherapy
  • Target volume delineation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Molecular imaging in radiotherapy planning for head and neck tumors. / Grégoire, Vincent; Chiti, Arturo.

In: Journal of Nuclear Medicine, Vol. 52, No. 3, 01.03.2011, p. 331-334.

Research output: Contribution to journalArticle

@article{fa988c31f51b4fe7b9622f610f9b03e0,
title = "Molecular imaging in radiotherapy planning for head and neck tumors",
abstract = "Molecular imaging uses noninvasive techniques to visualize various biologic pathways and physiologic characteristics of tumors and normal tissues. In relation to radiation therapy, PET with the tracer 18F-FDG offers a unique opportunity to refine the target volume delineation in patients with squamous cell carcinoma of the head and neck, in turn affecting dose distribution and, it is hoped, patient outcome. Even more so, in the framework of adaptive treatment and theragnostics, whereby dose distribution is adapted in space and time over the typical course of radiotherapy, molecular imaging with PET offers an elegant research avenue to further improve the therapeutic ratio. Such implementation could be of particular interest with tracers other than 18F-FDG, such as tracers of hypoxia and proliferation.",
keywords = "Dose painting, FDG, PET, Radiotherapy, Target volume delineation",
author = "Vincent Gr{\'e}goire and Arturo Chiti",
year = "2011",
month = "3",
day = "1",
doi = "10.2967/jnumed.110.075689",
language = "English",
volume = "52",
pages = "331--334",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "3",

}

TY - JOUR

T1 - Molecular imaging in radiotherapy planning for head and neck tumors

AU - Grégoire, Vincent

AU - Chiti, Arturo

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Molecular imaging uses noninvasive techniques to visualize various biologic pathways and physiologic characteristics of tumors and normal tissues. In relation to radiation therapy, PET with the tracer 18F-FDG offers a unique opportunity to refine the target volume delineation in patients with squamous cell carcinoma of the head and neck, in turn affecting dose distribution and, it is hoped, patient outcome. Even more so, in the framework of adaptive treatment and theragnostics, whereby dose distribution is adapted in space and time over the typical course of radiotherapy, molecular imaging with PET offers an elegant research avenue to further improve the therapeutic ratio. Such implementation could be of particular interest with tracers other than 18F-FDG, such as tracers of hypoxia and proliferation.

AB - Molecular imaging uses noninvasive techniques to visualize various biologic pathways and physiologic characteristics of tumors and normal tissues. In relation to radiation therapy, PET with the tracer 18F-FDG offers a unique opportunity to refine the target volume delineation in patients with squamous cell carcinoma of the head and neck, in turn affecting dose distribution and, it is hoped, patient outcome. Even more so, in the framework of adaptive treatment and theragnostics, whereby dose distribution is adapted in space and time over the typical course of radiotherapy, molecular imaging with PET offers an elegant research avenue to further improve the therapeutic ratio. Such implementation could be of particular interest with tracers other than 18F-FDG, such as tracers of hypoxia and proliferation.

KW - Dose painting

KW - FDG

KW - PET

KW - Radiotherapy

KW - Target volume delineation

UR - http://www.scopus.com/inward/record.url?scp=79952791247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952791247&partnerID=8YFLogxK

U2 - 10.2967/jnumed.110.075689

DO - 10.2967/jnumed.110.075689

M3 - Article

C2 - 21321281

AN - SCOPUS:79952791247

VL - 52

SP - 331

EP - 334

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 3

ER -